| NCT ID | NCT07407023 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yale University |
| Condition | Post Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 12 participants |
| Start Date | 2026-03-23 |
| Primary Completion | 2027-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 12 participants in total. It began in 2026-03-23 with a primary completion date of 2027-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized clinical trial compares the Portable Rehabilitation Interface (PoRI) device for rehabilitation of hand motor function in post-stroke patients with conventional hand therapy.
Eligibility Criteria
Inclusion Criteria: * Between 2 days and a maximum of 2 months have passed since the stroke event * 0-3/5 muscle strength * Participants with paralysis or sensorimotor function problems of the fingers of one or both hands. * Participants must be able to fit their hand comfortably into the device. Exclusion Criteria: * Less than 2 days or greater than 2 months have passed since the stroke event * 4-5/5 muscle strength * Vulnerable populations. * Inability of fingers and wrist to stretch to neutral during passive range of motion
Contact & Investigator
Necolle Morgado-Vega
PRINCIPAL INVESTIGATOR
Yale University
Frequently Asked Questions
Who can join the NCT07407023 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Post Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07407023 currently recruiting?
Yes, NCT07407023 is actively recruiting participants. Contact the research team at necolle.morgado-vega@yale.edu for enrollment information.
Where is the NCT07407023 trial being conducted?
This trial is being conducted at Milford, United States.
Who is sponsoring the NCT07407023 clinical trial?
NCT07407023 is sponsored by Yale University. The principal investigator is Necolle Morgado-Vega at Yale University. The trial plans to enroll 12 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.